Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Clinical trial NCT00988936 · COMPLETED

Trial details

NCT number: NCT00988936
Sponsor: Siemens Molecular Imaging
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Metastatic Colon/Rectum Cancer Non-squamous Non-small Cell Lung Cancer

Start date: 2009-09-01
Primary completion: 2012-03-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.